Explore the latest in cardiovascular disease risk factors, including diabetes, dyslipidemia, hypertension, tobacco and smoking, and more.
This cohort study examines the association between Mediterranean diet intake and cardiovascular risks and attempts to identify which biological mechanisms underlie the association among participants of the Women’s Health Study.
This cohort study evaluates the association of adherence and treatment intensity with cardiovascular outcomes in patients with documented cardiovascular disease, type 2 diabetes without cardiovascular disease or chronic kidney disease, and chronic kidney disease without cardiovascular disease.
This Medical News & Perspectives story examines the debate over whether opting for whole-fat dairy or nonfat dairy or avoiding dairy altogether is optimal for health.
This cohort study uses electronic health record data from the Clinical Practice Research Datalink database to examine the association between antihypertensive treatment prescriptions and all-cause mortality, cardiovascular disease, and adverse events in low-risk patients with mild hypertension.
This randomized clinical trial examines whether 6 months of daily docosahexaenoic acid supplementation during the second year of life improves developmental outcomes of children who were born preterm.
This systematic review and meta-analysis evaluates evidence from mendelian randomization studies to provide a less biased estimate of any association between obesity and cardiometabolic outcomes, specifically coronary artery disease, stroke, or type 2 diabetes, among nearly 1 million participants.
This cohort study investigates the association between maximum body mass index (BMI) and all-cause mortality for the original and offspring cohorts of the Framingham Heart Study without the consequences of reverse causality.
This Viewpoint describes the Million Hearts initiative, a US Centers for Disease Control and Prevention (CDC) and Centers for Medicare & Medicaid Services program aimed at preventing 1 million acute cardiovascular (CV) events by improving key cardiovascular disease (CVD) risk factors, and summarizes two 2018 CDC reports describing the burden of preventable CVD deaths and the slow rate of improving population-level measures of CV health.
This randomized survey study explores how communication tools and presentation formats influence the perception of the severity of atherosclerotic cardiovascular disease risk as well as the potential willingness to take medication therapy among patients in the Patient and Provider Assessment of Lipid Management Registry.
This autopsy study tests whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and provides a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size.
A 65-year-old woman with prior RCA NSTEMI treated with PCI presents with home BP fluctuations from <120/80 mm Hg to 200/100 mm Hg and mean 24-hour ambulatory measures of <160/90 mm Hg. How do you interpret the results?
This cohort study investigates associations between blood pressure classifications defined by the 2017 ACC/AHA guidelines in adults younger than 40 years and long-term CVD events including myocardial infarction, heart failure, and stroke.
This population-based cohort study uses a national insurance database data to estimate long-term rates of cardiovascular disease among young Korean adults with elevated blood pressure and stage 1 and 2 hypertension defined by the 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline.
This cohort study uses UK Whitehall II study data to characterize changes in cardiovascular risk factors over 10 years and associations between change in risk and incident cardiovascular events among people without baseline cardiovascular disease.
This Medical News article discusses the increased risk of future heart disease and stroke in women who experienced preeclampsia and other pregnancy complications.
This cohort study examines data from Atherosclerosis Risk in Communities Study to assess the association of midlife vascular and lifestyle risk factors with development of late-onset epilepsy.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: